Atlas Trials

Spanish Retrospective Study to Evaluate the Efficacy and Safety of Targeted Therapies After Pazopanib as First-line Therapy

Clinical trial NCT02282579 · COMPLETED

Trial details

NCT number
NCT02282579
Sponsor
Spanish Oncology Genito-Urinary Group
Status
COMPLETED
Study type
OBSERVATIONAL
Metastatic Renal Cell Carcinoma
Start date
2014-10-01
Primary completion
2015-02-01
Enrollment
300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.